Safe Insulin Use in the Hospital Setting

References

• Clement S, Braithwaite SS, Magee MF, et al. American Diabetes Association Diabetes in Hospitals Writing Committee. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004; 27(2): 553–591.
   PubMed Web of Science ®Google Scholar
• Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002; 87(3): 978–982.
   PubMed Web of Science ®Google Scholar
• Campbell RK. Etiology and effect on outcomes of hyperglycemia in hospitalized patients. Am J Health Syst Pharm. 2007; 64(10 suppl 6): S4–S8.
   Google Scholar
• Golovchenko I, Goalstone ML, Watson P, Brownlee M, Draznin B. Hyperinsulinemia enhances transcriptional activity of nuclear factor-κB induced by angiotensin II, hyperglycemia, and advanced glycosylation end products in vascular smooth muscle cells. Circ Res. 2000; 87(9): 746–752.
   PubMedGoogle Scholar
• Luna B, Feinglos MN. Drug-induced hyperglycemia. JAMA. 2001; 286(16): 1945–1948.
   PubMedGoogle Scholar
• Rosmarin DK, Wardlaw GM, Mirtallo J. Hyperglycemia associated with high, continuous infusion rates of total parenteral nutrition dextrose. Nutr Clin Pract. 1996; 11 (4): 151–156.
   PubMedGoogle Scholar
• Cheung NW, Napier B, Zaccaria C, Fletcher JP. Hyperglycemia is associated with adverse outcomes in patients receiving total parenteral nutrition. Diabetes Care. 2005; 28(10): 2367–2371.
   PubMedGoogle Scholar
• Hollingdal M, Juhl CB, Dall R, et al. Glucocorticoid induced insulin resistance impairs basal but not glucose entrained high-frequency insulin pulsatility in humans. Diabetologia. 2002; 45(1): 49–55.
   PubMedGoogle Scholar
• Weintraub WS, Wenger NK, Jones EL, Craver JM, Guyton RA. Changing clinical characteristics of coronary surgery patients. Differences between men and women. Circulation. 1993; 88 (5 pt 2): 1179–1186.
   Google Scholar
• Fumary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg. 1999; 67(2): 352–360.
   PubMedGoogle Scholar
• Thourani VH, Weintraub WS, Stein B, et al. Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg. 1999; 67(4): 1045–1052.
   PubMedGoogle Scholar
• Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc. 2003; 78(12): 1471–1478.
   PubMed Web of Science ®Google Scholar
• Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001; 345(19): 1359–1367.
   PubMed Web of Science ®Google Scholar
• Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract. 2004; 10(suppl 2): 21–33.
   PubMedGoogle Scholar
• Wahab NN, Cowden EA, Pearce NJ, Gardner MJ, Merry H, Cox JL; ICONS Investigators. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol. 2002; 40(10): 1748–1754.
   PubMed Web of Science ®Google Scholar
• Guvener M, Pasaoglu I, Demircin M, Oc M. Perioperative hyperglycemia is a strong correlate of postoperative infection in type II diabetic patients after coronary artery bypass grafting. Endocr J. 2002; 49(5): 531–537.
   PubMed Web of Science ®Google Scholar
• Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006; 354(5): 449–461.
   PubMed Web of Science ®Google Scholar
• Van den Berghe G, Wouters PJ, Kesteloot K, Hilleman DE. Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients. Crit Care Med. 2006; 34(3): 612–616.
   PubMed Web of Science ®Google Scholar
• Finfer S, Chittock DR, Su SY, et al. NICE-SUGAR Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009; 360(13): 1283–1297.
   PubMed Web of Science ®Google Scholar
• Olson L, Muchmore J, Lawrence CB. The benefits of inpatient diabetes care: improving quality of care and the bottom line. Endocr Pract. 2006; 12(suppl 3): 35–42.
   PubMedGoogle Scholar
• Estrada CA, Young JA, Nifong LW, Chitwood WR Jr. Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting. Ann Thorac Surg. 2003; 75(5): 1392–1399.
   PubMed Web of Science ®Google Scholar
• Krinsley JS, Jones RL. Cost analysis of intensive glycemic control in critically ill adult patients. Chest. 2006; 129(3): 644–650.
   PubMed Web of Science ®Google Scholar
• Fumary AP, Wu Y. Clinical effects of hyperglycemia in the cardiac surgery population: the Portland Diabetic Project. Endocr Pract. 2006; 12(suppl 3): 22–26.
   PubMedGoogle Scholar
• ACE/ADA Task Force on Inpatient Diabetes. American College of Endocrinology and American Diabetes Association consensus statement on inpatient diabetes and glycemic control. Endocr Pract. 2006; 12(4): 458–468.
   PubMedGoogle Scholar
• ACE/ADA Task Force on Inpatient Diabetes. American College of Endocrinology and American Diabetes Association consensus statement on inpatient diabetes and glycemic control. Diabetes Care. 2006; 29(8): 1955–1962.
   PubMedGoogle Scholar
• American Diabetes Association. Standards of medical care in diabetes—2008. Diabetes Care. 2008; 31(suppl 1): S12–S54.
   PubMed Web of Science ®Google Scholar
• Beckley ET. AACE and ADA call for adoption of inpatient glucose control strategy. DOC News. 2006; 3(4): 1–10.
   Google Scholar
• Moghissi ES, Korytkowski MT, Dinardo M, et al; American Association of Clinical Endocrinologists; American Diabetes Association. American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control. Endocr Pract. 2009; 15(4): 353–369.
   PubMed Web of Science ®Google Scholar
• Kurtzhals P, Schäffer L, Sørensen A, et al. Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes. 2000; 49(6): 999–1005.
   PubMed Web of Science ®Google Scholar
• White JR Jr, Campbell RK, Hirsch I. Insulin analogues: new agents for improving glycemic control. Postgrad Med. 1997; 101(2): 58–60.
   PubMed Web of Science ®Google Scholar
• Allen J. Insulins. Pharmacist's Letter. 2006; 22(9): 220910. Updated December 2008.
   Google Scholar
• Fedutes BA, Donihi AC, Culley CM, McCreery BJ, Ansani NT. An evidence-based summary of insulin analogues. P&T. 2005; 30(2): 112–123.
   Google Scholar
• Juneja R. Hyperglycemia management in the hospital: about glucose targets and process improvements. Postgrad Med. 2008; 120(4): 38–50.
   PubMed Web of Science ®Google Scholar
• DeSantis AJ, Schmeltz LR, Schmidt K, et al. Inpatient management of hyperglycemia: the Northwestern experience. Endocr Pract. 2006; 12(5): 491–505.
   PubMedGoogle Scholar
• Donaldson S, Villanuueva G, Rondinelli L, Baldwin D. Rush University guidelines and protocols for the management of hyperglycemia in hospitalized patients: elimination of the sliding scale and improvement of glycemic control throughout the hospital. Diabetes Educ. 2006; 32(6): 954–962.
   PubMedGoogle Scholar
• Zimmerman CR, Mlynarek ME, Jordan JA, Rajda CA, Horst HM. An insulin infusion protocol in critically ill cardiothoracic surgery patients. Ann Pharmacother. 2004; 38(7–8): 1123–1129.
   PubMedGoogle Scholar
• Goldberg PA, Siegel MD, Sherwin RS, et al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care. 2004; 27(2): 461–467.
   PubMed Web of Science ®Google Scholar
• Markovitz LJ, Wiechmann RJ, Harris N, et al. Description and evaluation of a glycemic management protocol for patients with diabetes undergoing heart surgery. Endocr Pract. 2002; 8(1): 10–18.
   PubMedGoogle Scholar
• International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009; 32(7): 1327–1334.
   PubMed Web of Science ®Google Scholar
• Schmeltz L. System-wide formulary change from regular insulin sliding scales to insulin aspart sliding scales did not improve overall glycemic control [abstract]. Diabetes 2008; 57(suppl 1): A162.
   Google Scholar
• Thomas PG, Lipska KJ, Bozzo JE, Inzucchi SE. 1.5 million fingersticks later: benchmarking inpatient glycemic control from a national sample of hospitals. Presented at: 69th Annual Meeting of the American Diabetes Association; June 5–9, 2009; New Orleans, LA. Abstract 397-P.
   Google Scholar
• Bagshaw SM, Egi M, George C, Bellomo R; Australia New Zealand Intensive Care Society Database Management Committee. Early blood glucose control and mortality in critically ill patients in Australia. Crit Care Med. 2009; 37(2): 463–470.
   PubMed Web of Science ®Google Scholar
• Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med. 2007; 35(10): 2262–2267.
   PubMed Web of Science ®Google Scholar
• Kosiborod M, Inzucchi SE, Goyal A, et al. Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction. JAMA. 2009; 301(15): 1556–1564.
   PubMedGoogle Scholar
• American Society of Health-System Pharmacists. Professional practice recommendations for safe use of insulin in hospitals, http://www.ashp.org/s_ashp/docs/files/Safe_Use_of_Insulin.pdf. Accessed October 12, 2009.
   Google Scholar
• Schmeltz LR, DeSantis AJ, Schmidt K, et al. Conversion of intravenous insulin infusions to subcutaneously administered insulin glargine in patients with hyperglycemia. Endocr Pract. 2006; 12(6): 641–650.
   PubMedGoogle Scholar
• MedicineNet.com. Diabetes: Choosing and Using Your Glucose Meter. http://www.medicinenet.com/script/main/art.asp?articlekey=20554. Accessed October 12, 2009.
   Google Scholar
• Louie RF, Tang Z, Sutton, DV, Lee JH, Kost GJ. Point-of-care glucose testing: effects of critical care variables, influence of reference instruments, and a modular glucose meter design. Arch Pathol Lab Med. 2000; 124(2): 257–266.
   PubMedGoogle Scholar
• Institute for Safe Medication Practices. Considering insulin pens for routine hospital use? Consider this. http://ismp.org/Newsletters/acutecare/articles/20080508.asp. Accessed October 12, 2009.
   Google Scholar
• Joint Commission on the Accreditation of Health Organizations. Management of the patient with diabetes in the inpatient setting, http://www.jointcommission.org/NR/rdonlyres/1F9B67C2-72A6-4DC3-A047-15BeB394FE3C/0/Diabetes_Addendum.pdf. Accessed October 12, 2009.
   Google Scholar
• Institute for Healthcare Improvement. Implement effective glucose control. http://www.ihi,org/IHI/Topics/CriticalCare/IntensiveCare/Changes/ImplementEffectiveGlucoseControl.htm. Accessed October 12, 2009.
   Google Scholar
• Newton CA, Barnhill K, Massey JA, Moore LM, Whitfield AM. Rapid glycemic improvements with computer-based IV insulin in a cardiac ICU. Diabetes. 2007; 56(suppl 1): A122
   Google Scholar
• Meece J. Effect of insulin pen devices on the management of diabetes mellitus. Am J Health Sys Pharm. 2008; 65(11): 1076–1082.
   PubMed Web of Science ®Google Scholar
• Davis EM, Christensen CM, Nystrom KK, Foral PA, Destache C. Patient satisfaction and costs associated with insulin administered by pen device or syringe during hospitalization. Am J Health Syst Pharm. 2008; 65(14): 1347–1357.
   PubMed Web of Science ®Google Scholar
• Lantus® (insulin glargine [rDNA origin] injection)[prescribing information], Bridgewater, NJ: sanofi-aventis US, LLC; 2007.
   Google Scholar
• NovoNordisk. NovoFine® product brochure. http://www.novonordisk.com/diabetes/public/needles/novofine/manual.asp. Accessed October 12, 2009.
   Google Scholar
• BD AutoShieldTM Pen Needle instructions for use. http://www.bd.com/injection/products/autoshield/. Accessed October 12, 2009.
   Google Scholar
• U.S. Food and Drug Administration. FDA: Insulin pens and insulin cartridges must not be shared. http://www.fda.gov/bbs/topics/NEWS/2009/NEW01976-.html. Accessed October 12, 2009.
   Google Scholar
• Clore JN, Thurby-Hay L. Which basal insulin should be used in patients with type 2 diabetes mellitus? Curr Diab Rep. 2007; 7(5): 348–352.
   PubMedGoogle Scholar
• Pieber TR, Treichel HC, Hompesch B, et al. Comparison of insulin detemir and insulin glargine in subjects with Type 1 diabetes using intensive insulin therapy. Diabet Med. 2007; 24(6): 635–642.
   PubMed Web of Science ®Google Scholar
• Rossetti P, Porcellati F, Fanelli CG, Perriello G, Tortone E, Bolli GB. Superiority of insulin analogues versus human insulin in the treatment of diabetes mellitus. Arch Physiol Biochem. 2008; 114(1): 3–10.
   PubMedGoogle Scholar
• Tibaldi J. Actions of insulin beyond glycemic control: a perspective on insulin detemir. Adv Ther. 2007; 24(4): 868–882.
   PubMedGoogle Scholar
• Trujillo JM, Barsky EE, Greenwood BC, et al. Improving glycemic control in medical inpatients: a pilot study. J Hosp Med. 2008; 3(1): 55–63.
   PubMedGoogle Scholar
• Institute for Safe Medication Practices—Canada. Insulin errors. ISMP Canada Safety Bulletin. 2003; 3(4): 1–2.
   Google Scholar
• Apidra* (insulin glulisine [rDNA origin] injection) [prescribing information], Bridgewater, NJ: Sanofi aventis US, LLC; 2009.
   Google Scholar